Dexilant (Takeda Pharmaceuticals America, Inc.)
Welcome to the PulseAid listing for the Dexilant drug offered from Takeda Pharmaceuticals America, Inc.. This Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Takeda Pharmaceuticals America, Inc. |
NON-PROPRIETARY NAME: | dexlansoprazole |
SUBSTANCE NAME: | DEXLANSOPRAZOLE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE, DELAYED RELEASE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2010-04-12 |
END MARKETING DATE: | 0000-00-00 |
Dexilant HUMAN PRESCRIPTION DRUG Details:
Item Description | Dexilant from Takeda Pharmaceuticals America, Inc. |
LABELER NAME: | Takeda Pharmaceuticals America, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 30(mg/1) |
START MARKETING DATE: | 2010-04-12 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 64764-171_5a2130f7-fd80-40ef-8190-51e68f147bb0 |
PRODUCT NDC: | 64764-171 |
APPLICATION NUMBER: | NDA022287 |
Other DEXLANSOPRAZOLE Pharmaceutical Manufacturers / Labelers: